| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124576A2 Method for preparing solid phase conjugate vaccines |
| 08/22/2001 | EP1124544A1 Dry powder pharmaceutical formulation |
| 08/22/2001 | EP1124535A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP0809516B1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
| 08/22/2001 | EP0725794B1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 08/22/2001 | EP0697880B1 Inhibition of leukocyte adhesion |
| 08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
| 08/22/2001 | CN1309705A IL-2 selective agonists and antagonists |
| 08/22/2001 | CN1309662A Chemotaxis-inhibiting protein of i(staphylococcus) (CHIPS) and its use |
| 08/22/2001 | CN1309660A Phosphinous and phosphonic acid derivs. used as medicaments |
| 08/22/2001 | CN1309642A Novel 1,2,5-trisubstd. 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effects, method for production and use as medicam ent |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309552A Pharmaceutical, hygienic and/or cosmetic compositions contg. sea water and uses |
| 08/22/2001 | CN1308937A Method for preparing microcapsule |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277962 Receptor on the surface of activated t-cells: act-4 |
| 08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
| 08/21/2001 | US6277888 Drug composition |
| 08/21/2001 | US6277839 Antiinflammatory agents, antipyretics, analgesics; side effect reduction |
| 08/21/2001 | US6277635 Use of interleukin-10 to produce a population of suppressor cells |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
| 08/21/2001 | US6277572 Human NADH dehydrogenase subunits |
| 08/21/2001 | US6277383 Ryegrass pollen allergen |
| 08/21/2001 | US6277357 Ketotricyclo[5.2.1.0]decane derivatives |
| 08/21/2001 | CA2319308C Pharmaceutical agents |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/21/2001 | CA2013324C Pteridin-4(3h)-ones, process for their preparation and drugs containing them |
| 08/16/2001 | WO2001059142A1 Antibody gene therapy with adeno-associated viral vectors |
| 08/16/2001 | WO2001059137A1 Method for remodelling cell wall polysaccharide structures in plants |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059072A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001059067A2 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058941A1 Cytokine activity regulator molecules from tick salivary glands |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058922A2 Method and compositions for treating hepatocellular cancer |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058900A1 1h-imidazopyridine derivatives |
| 08/16/2001 | WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 08/16/2001 | WO2001058897A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 08/16/2001 | WO2001058896A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 08/16/2001 | WO2001058895A1 Benzofuran carboxamides and their therapeutic use |
| 08/16/2001 | WO2001058892A1 Tyrosine derivatives with anti-leukotriene activity |
| 08/16/2001 | WO2001058889A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 08/16/2001 | WO2001058886A1 Dipeptide nitrile cathepsin k inhibitors |
| 08/16/2001 | WO2001058879A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | WO2001058871A1 Piperidyl carboxylic acids as integrin antagonists |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001058526A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | WO2001058488A1 Remedies for sjoegren's syndrome |
| 08/16/2001 | WO2001058486A2 Immunomodulatory effective compositions, methods for the production thereof and their use |
| 08/16/2001 | WO2001058483A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 08/16/2001 | WO2001058481A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 08/16/2001 | WO2001058478A1 Antigenic complexes and methods |
| 08/16/2001 | WO2001058452A1 Thermal ablation of tissue |
| 08/16/2001 | WO2001058443A1 TNF- α INHIBITORS |
| 08/16/2001 | WO2001058423A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases |
| 08/16/2001 | WO2001058283A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | WO2001058241A2 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 08/16/2001 | WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 08/16/2001 | WO2001010385A3 1,4-substituted 4,4-diaryl cyclohexanes |
| 08/16/2001 | WO2001010381A3 Methods for treating or preventing pain and anxiety |
| 08/16/2001 | WO2001009173A3 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 08/16/2001 | WO2001009119A3 Chemokine receptor antagonists |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007080A3 Method for enhancing production performance in an animal |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | WO2000056356B1 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 08/16/2001 | WO2000050077A9 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
| 08/16/2001 | US20010014741 Antiallergens, antihistamines, bronchodilator |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123711A1 Vaccine preparations containing attenuated toxin |
| 08/16/2001 | EP1123414A1 Antisense modulation of integrin alpha 4 expression |
| 08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
| 08/16/2001 | EP1123312A2 Human rna binding proteins |
| 08/16/2001 | EP1123309A2 Cyclic tetrapeptides and their use as histone deacetylase inhibitor |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123295A1 Bicyclic nitrogen heterocycles |
| 08/16/2001 | EP1123288A1 Vitreous form of known bradykinin antagonist |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123274A1 Substituted phenyl derivatives, their preparation and use |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1123115A1 Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l |
| 08/16/2001 | EP1123108A1 Isolated peptides which bind to hla-b35 molecules |